J&J, BARDA pick 7 startups to back in fight against COVID-19—and beyond Biotech behind AstraZeneca's COVID-19 vaccine advances next-gen prospect Bayer backs Triumvira to take CAR alternative into clinic Sponsored: Improve outcomes for TIL therapies by tackling process challenges Dermavant's psoriasis cream hits the mark in phase 3, teeing up FDA filing Amid gene therapy hold, Solid Bio's ex-CMO joins Apic CRISPR treats obesity in mice by turning harmful fat into energy-burning cells Abbott to ship millions of $5, card-sized coronavirus tests offering 'digital health passes' Featured Story | By Amirah Al Idrus As the world scrambles to develop diagnostics, treatments and vaccines for COVID-19, one big question looms: How will we face the next pandemic? Johnson & Johnson and the U.S. Biomedical Advanced Research and Development Authority are teaming up once again to answer that. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor Vaccitech has received U.K. government funding for a COVID-19 vaccine that it thinks can improve on first-generation prospects such as the AstraZeneca jab it helped develop. read more By Nick Paul Taylor Bayer has co-led a $55 million investment in cell therapy startup Triumvira Immunologics. Triumvira will use the series A funding to run clinical trials of cell therapies that are directed by an alternative to CARs. read more Sponsored By: Cytiva The efficacy of TIL therapies depends on how the original tumor samples are collected, harvested, and processed. read more By Amirah Al Idrus Two years ago, Dermavant forked over £150 million upfront to get its hands on GlaxoSmithKline’s phase 3-ready psoriasis cream. Now, with positive phase 3 data in hand, the company is ushering the drug toward an FDA filing in 2021. The cream, tapinarof, outshone an inactive cream in two identical phase 3 studies that together enrolled more than 1,000 patients read more By Ben Adams A month after the FDA kept its clinical hold on Solid Biosciences’ experimental gene therapy treatment, the biotech’s former chief medical officer has landed at Apic. read more By Angus Liu A research team led by scientists at Harvard University used the CRISPR-Cas9 gene-editing tool to engineer harmful white fat so that it would take on the properties of calorie-burning brown fat. They believe the advancement will open up the possibility of cell therapies to combat obesity and other metabolic diseases. read more By Conor Hale The FDA has given its green light to a new coronavirus test from Abbott, which will be sold for $5 and fits entirely on a device about the size of a credit card. read more Enrollment Showcase | Presented by: Biotility Taught by experienced professionals, Biotility’s online short courses provide the knowledge and practical skills valued by the bioscience industry. Enhance your career through coursework in one of our certificate pathways, including Document Management, Operations Management, and Quality Management. Learn more. |
| |
|---|
|
Resources Sponsored by: LexisNexis Risk Solutions Traditionally, pharma companies use a combination of prescription data & internal sales reports to look for potential buyers. Such practice provides only a LIMITED VIEW without competitor information. Sponsored by: Optum Download the whitepaper by Optum to see how novel data platforms can uncover hidden insights on medication adherence helping life sciences companies maximize product utilization. Sponsored by: Evotec Two informative webcasts will present practical and methodological approaches to preclinical drug abuse liability assessment Sponsored by: Oracle Health Sciences Patient-facing digital technologies are playing an important role in clinical trials for new drugs and medical devices, to the point where conducting virtual trials is becoming mainstream. But terms like remote trials, direct-to-patient trials, hybrid trials, decentralized trials, and more all add to the confusion of what makes a trial "virtual." Sponsored by: Oracle Health Sciences The research conducted here is to help understand and solve the top challenges in clinical operations, to remove barriers that are slowing down our ability to bring new drugs to market as quickly as possible to patients waiting in need. Sponsored by: Thermo Fisher Scientific How to select the right dosage form for your Phase I clinical supply. Sponsored by: Thermo Fisher Scientific Quality by Design (QbD) reduces risk within drug development, while bringing therapies to market quicker. Sponsored by: Catalent Pharmaceutical and biotech companies are spending years developing drugs or promising new biologics, all with the hopes of saving or enhancing patients’ lives. It’s a “race to the finish” in some cases, and the quicker a company can get its product to patients, the better. Sponsored by: Acorn AI by Medidata, a Dassault Systèmes company Case Study: Oncology-focused pharmaceutical company strengthens product launch by identifying hundreds of high-value physicians with Acorn AI. Sponsored by: Paysign Download the whitepaper for a solution designed to connect manufacturers, pharmacists, and patients. In this special guide, you will learn not just about the law but about the portal platform designed to change the entire process for all. Sponsored by: Cardinal Health 3PL Services Identifying opportunities to simplify channel strategies and business processes for biopharma companies, their customers and patients. Sponsored by: Catalent In a BioPharma Dive industry survey, planning and forecasting were identified as top concerns for trial sponsors. In response to this need, the CSM team at Catalent has developed a methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management. Sponsored by: PRA Health Sciences Drug developers and stakeholders must find ways to collaborate, rather than compete, as the RACE Act prompts the need for more pediatric research. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Biomanufacturing Class. Live, Online. Oct 2. Register Today! October 2, 2020 | 9am - 3:30pm ET Drug Development Immersion: Live, Online Course October 21-22, 2020 | 9am - 3:30pm ET BioBasics 101: The Biology of Biotech for the Non-Scientist: Live, Online Course November 12-13, 2020 | 9am - 3:30pm ET Drug Development Boot Camp® VIRTUAL 2020 November 18-19, 2020 | Register now! Pre-Boot Camp training ongoing now | Due to COVID19 provisions – training will be conducted VIRTUALLY | Same excellent total immersion training in new medicine development will be made available to experts who want to make a difference to patients. | 